BLISSGVS — Bliss GVS Pharma Share News
0.000.00%
Last trade - 00:00- IN₹66.31bn
- IN₹64.93bn
- IN₹9.27bn
Brief: Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
Brief: Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
India's Bliss GVS Pharma gains on Anupam Rasayan's plan to buy stake
Brief: Bliss GVS Pharma Dec-Quarter Consol Net Profit 232.7 Million Rupees
Brief: Bliss Gvs Pharma Appoints S. N. Kamath As Managing Director For Three Years
Brief: Bliss GVS Pharma Appoints S. N. Kamath As Managing Director
Brief: Bliss GVS Pharma Incorporates Theralife Pharma In Kenya
Brief: Bliss GVS Pharma Sept-Quarter Consol Net Profit 272.5 Million Rupees
Brief: Bliss Gvs Pharma Receives Tax Demand Of 166.9 Million Rupees From Tax Department
Appoints Narsimha Shibroor Kamath As CEO
Brief: Bliss GVS Pharma June-Quarter Consol Net Profit 430.4 Million Rupees
Brief: Bliss GVS Pharma Gets Show Cause From Tax Department Over Recovery Of Refund Of 66.4 Million Rupees
Brief: Bliss GVS Pharma Says Rising Pharma Holdings Gets Final Approval From USFDA For Mesalamine Suppositories
Brief: Bliss GVS Pharma To Consider Issuance Of Sweat Equity Shares
India's Bliss GVS Pharma surges on quarterly profit climb
Brief: Bliss GVS Pharma June-Quarter Consol Net Profit 207 Mln Rupees
Brief: Bliss Gvs Pharma Approves Internal Restructuring Of Foreign Units
Brief: Bliss Gvs Pharma Says Assistant Commission Of State Tax Maharashtra Initiated Search On Sept 6 At Certain Premises Of Co
India's Bliss GVS Pharma sinks on qtrly profit slide